Edition:
India

Novozymes A/S (NZYMb.CO)

NZYMb.CO on Copenhagen Stock Exchange

314.70DKK
13 Nov 2019
Change (% chg)

-- (--)
Prev Close
kr.314.70
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
512,577
52-wk High
kr.332.90
52-wk Low
kr.260.10

Latest Key Developments (Source: Significant Developments)

Novozymes CEO Expects Downturn In U.S. Bioethanol Market To Continue In Q4
Wednesday, 23 Oct 2019 

Oct 23 (Reuters) - Novozymes' CEO Peder Holk Nielsen told Reuters::NOVOZYMES CEO SAYS U.S. BIOETHANOL VOLUMES HAVE DETEROIATED SEVERELY SINCE END-SEPTEMBER; EXPECTS DOWNTURN TO CONTINUE IN FOURTH QUARTER.NOVOZYMES CEO SAYS RECENT DOWNTURN IN U.S. BIOETHANOL MARKET IS MAINLY DUE TO POLITICAL UNCERTAINTY.NOVOZYMES CEO SAYS CAN'T DO ANYTHING TO MITIGATE THE NEGATIVE IMPACT FROM THE SUBDUED U.S. BIOETHANOL MARKET.NOVOZYMES CEO SAYS NEW FRESHNESS PLATFORM HAS BEEN WELL RECEIVED BY PROCTER & GAMBLE WHICH IS PUSHING AHEAD WITH LAUNCHES.  Full Article

Novozymes Q3 EBIT At DKK 852 Million, Below Estimates
Wednesday, 23 Oct 2019 

Oct 23 (Reuters) - Novozymes A/S ::REG-INTERIM REPORT FOR THE FIRST NINE MONTHS OF 2019.Q3 REVENUE DKK 3,704 MILLION (REFINITIV POLL DKK 3,761 MILLION).Q3 EBIT DKK 852 MILLION (REFINITIV POLL DKK 891.0 MILLION).Q3 NET PROFIT DKK 638 MILLION (REFINITIV POLL DKK 701.5 MILLION).AS ANNOUNCED ON OCTOBER 9, PERFORMANCE FOR THE FIRST NINE MONTHS OF 2019 WAS WEAKER THAN EXPECTED.AND WHILE Q3 GREW ORGANICALLY, WE CONTINUED TO SEE A DIFFICULT US ETHANOL MARKET, WEAK GLOBAL AGRICULTURAL MARKETS AND A STARCH BUSINESS UNDER PRESSURE LEADING US TO ADJUST THE OUTLOOK..KEEPS OUTLOOK ANNOUNCED ON OCT 9.FOOD & BEVERAGES DECLINED BY 1% ORGANICALLY AND GREW BY 1% IN DKK YEAR-OVER-YEAR IN THE FIRST NINE MONTHS OF 2019.SALES IN AGRICULTURE & FEED DECLINED BY 3% ORGANICALLY AND BY 5% IN DKK YEAR-OVER-YEAR IN THE FIRST NINE MONTHS OF 2019, SALES IN Q3 GREW 3% ORGANICALLY AND DECLINED 4% IN DKK COMPARED TO LAST YEAR.BIOENERGY SALES IN THE THIRD QUARTER DECLINED BY 5% ORGANICALLY AND BY 2% IN DKK..SALES IN ASIA PACIFIC DECLINED ORGANICALLY BY 5% IN THE FIRST NINE MONTHS OF 2019 COMPARED WITH THE SAME PERIOD OF 2018.HOUSEHOLD CARE IN THE THIRD QUARTER, SALES GREW BY 5% ORGANICALLY AND BY 7% IN DKK..A LARGE PART OF THE ORGANIC SALES DECLINE RELATED TO THE ANNUALIZATION OF THE NEGATIVE EFFECTS FROM THE SANCTIONS ON IRAN.FOOD & BEVERAGES IN THE THIRD QUARTER OF 2019, SALES GREW BY 1% ORGANICALLY AND BY 3% IN DKK..  Full Article

Novozymes CEO Peder Holk Nielsen To Leave Position
Tuesday, 15 Oct 2019 

Oct 15 (Reuters) - Novozymes A/S ::REG-CHANGE TO THE EXECUTIVE LEADERSHIP TEAM.PEDER HOLK NIELSEN TO LEAVE THE POSITION AS PRESIDENT AND CEO OF NOVOZYMES IN EARLY 2020.THE BOARD EXPECTS TO BE ABLE TO ANNOUNCE A NEW CEO WITHIN A SHORT PERIOD OF TIME.SAYS NOVOZYMES HAS BEEN CHALLENGED IN RECENT YEARS AND NEEDS TO DELIVER HIGHER REVENUE GROWTH.NEW CEO WILL BE AN EXTERNAL FROM OUTSIDE THE NOVO GROUP.CHANGE IS NOT EXPECTED TO AFFECT THE FINANCIAL OUTLOOK FOR 2019..  Full Article

U.S. Water And Novozymes Settle U.S. Patent Infringement Action Relating To Phytout Technology
Monday, 23 Sep 2019 

Sept 23 (Reuters) - Novozymes A/S ::U.S. WATER AND NOVOZYMES SETTLE U.S. PATENT INFRINGEMENT ACTION RELATING TO PHYTOUT® TECHNOLOGY.TERMS OF SETTLEMENT ARE CONFIDENTIAL.U.S. WATER SERVICES, INC. AND NOVOZYMES HAVE SETTLED A U.S. PATENT INFRINGEMENT ACTION U.S. WATER BROUGHT AGAINST NOVOZYMES ALLEGING INFRINGEMENT OF U.S. PATENT NOS. 8,415,137 AND 8,609,399, AND VALIDITY OF PATENTS WAS UPHELD BY COURT OF APPEALS FOR FEDERAL CIRCUIT.  Full Article

Novozymes Q2 EBIT At DKK 1.19 Bln, Slightly Below Expectations
Thursday, 8 Aug 2019 

Aug 8 (Reuters) - Novozymes A/S ::REG-INTERIM REPORT FOR THE FIRST HALF OF 2019.Q2 REVENUE DKK 3,458 MILLION (REFINITIV POLL DKK 3.60 BILLION).Q2 EBIT DKK 1,189 MILLION (REFINITIV POLL DKK 1.21 BILLION).Q2 NET PROFIT DKK 898 MILLION (REFINITIV POLL DKK 918.65 MILLION).2019 OUTLOOK CONFIRMED ON ALL FRONTS FOLLOWING THE ADJUSTMENTS COMMUNICATED ON JUNE 6.NEGATIVE IMPACT FROM US AGRICULTURE, THE MIDDLE EAST, WEAKNESS IN STARCH IN ASIA PACIFIC AND PRICE ADJUSTMENTS IN US BAKING ENZYMES.SOFTNESS IN US AGRICULTURE AND SOME EMERGING MARKETS, INCLUDING THE MIDDLE EAST, HAS CREATED HEADWINDS.DEVELOPED MARKETS FLAT; 8% ORGANIC SALES DECLINE IN EMERGING MARKETS, MAINLY DUE TO THE MIDDLE EAST BUT ALSO SOFTNESS IN SOME EMERGING MARKETS, SUCH AS CHINA.WE’RE CONFIDENT SALES GROWTH WILL ACCELERATE IN THE SECOND HALF OF THE YEAR AS THE FRESHNESS PLATFORM, BIOAG AND BIOENERGY ALL STEP UP, AND THE MIDDLE EAST COMPARISON EASES.THE BOARD OF DIRECTORS PROPOSES THE ELECTION OF MR. CEES DE JONG AS A NEW BOARD MEMBER.  Full Article

Novozymes Sees 2019 Net Profit Growth Of 3-8%
Thursday, 6 Jun 2019 

June 6 (Reuters) - Novozymes A/S ::REG-COMPANY ANNOUNCEMENT.HAS EXPERIENCED A DECLINE OF 2% IN ORGANIC SALES IN THE FIRST FIVE MONTHS OF 2019.FULL-YEAR ORGANIC SALES GROWTH OUTLOOK FOR 2019 IS NOW 1-3%.SEES 2019 NET PROFIT GROWTH OF 3-8%.NOVOZYME- RECOVERY OF US BIOENERGY BUSINESS HAS NOT PROGRESSED AS EXPECTED, AND DEMAND IN SOME EMERGING MARKETS IS SOFT.SEES 2019 CAPEX AT DKK 1.0-1.2 BILLION.NOVOZYME- "STRONGER GROWTH IN 2H VERSUS. 1H Y/Y STILL EXPECTED".SEVERE WEATHER IN THE US MIDWEST ARE IMPACTING GRAIN-PROCESSING VOLUMES AND CHALLENGING THE PLANTING SEASON.SEES 2019 EBIT MARGIN AT 28-29% SUPPORTED BY PRODUCTIVITY GAINS, SALE OF PHARMA-RELATED TECHNOLOGY.  Full Article

Novozymes Q1 EBIT At DKK 895 Mln, Below Expectations
Wednesday, 24 Apr 2019 

April 24 (Reuters) - Novozymes A/S ::REG-INTERIM REPORT FOR THE FIRST 3 MONTHS OF 2019.FULL-YEAR EARNINGS OUTLOOK MAINTAINED AFTER EARLY-APRIL UPGRADE.Q1 TOTAL SALES DKK 3.48 BLN; RTRS POLL DKK 3.60 BLN.NARROWED SALES GROWTH GUIDANCE FOLLOWING WEAKNESS IN US BIOETHANOL..Q1 NET PROFIT DOWN 14% Y/Y DUE TO LOWER EBIT AND HEDGING LOSSES.Q1 EBIT DKK 895 MLN; RTRS POLL DKK 1.02 BLN.FLOODS IN THE MIDWEST HAVE MADE IT TOUGHER FOR OUR CUSTOMERS..IT WILL BE DIFFICULT TO REACH THE TOP END OF THE GUIDED ORGANIC SALES GROWTH RANGE, AND WE ADJUST OUR OUTLOOK TO 3-5%..SAYS MIDDLE EAST COMPARISON GETS EASIER.SALES TO THE HOUSEHOLD CARE INDUSTRY DECLINED BY 3% ORGANICALLY AND BY 2% IN DKK IN THE FIRST QUARTER OF 2019 COMPARED WITH THE FIRST QUARTER OF 2018.DEVELOPED MARKETS FLAT; 10% ORGANIC SALES DECLINE IN EMERGING MARKETS, WITH THE MIDDLE EAST AS THE MAIN DRAG.NEGATIVE IMPACT FROM THE MIDDLE EAST, FEED ENZYMES AND THE PLANNED PRICE REDUCTIONS IN US BAKING ENZYMES.FOOD & BEVERAGES SALES DECLINED BY 2% ORGANICALLY AND GREW BY 1% IN DKK IN THE FIRST QUARTER OF 2019 COMPARED WITH THE SAME PERIOD LAST YEAR.Q1 SALES TO BIOENERGY DECLINED BY 8% ORGANICALLY AND BY 4% IN DKK COMPARED WITH THE FIRST QUARTER OF 2018..STOCK BUYBACK PROGRAM OF UP TO DKK 2BN TO BE INITIATED APRIL 25, 2019..  Full Article

Elanco Announces Collaboration Agreement With Novozymes For Nutritional Health Innovation
Friday, 2 Nov 2018 

Nov 2 (Reuters) - Elanco Animal Health Inc ::ELANCO ANNOUNCES COLLABORATION AGREEMENT WITH NOVOZYMES FOR NUTRITIONAL HEALTH INNOVATION.ELANCO ANIMAL HEALTH INC - RESEARCH AND DEVELOPMENT COLLABORATION WITH NOVOZYMES A/S TO DEVELOP NUTRITIONAL HEALTH PRODUCTS FOR BEEF CATTLE AND DAIRY COWS GLOBALLY.ELANCO ANIMAL HEALTH INC - COMPANIES WILL COLLABORATE TO DEVELOP A RESEARCH AND DEVELOPMENT PIPELINE AND COMMERCIALIZE PRODUCTS IN NEXT DECADE..  Full Article

BioAg Alliance Announces Updated Research And Development Pipeline
Thursday, 4 Jan 2018 

Jan 4 (Reuters) - BioAg Alliance::BIOAG ALLIANCE - ANNOUNCED UPDATED RESEARCH AND DEVELOPMENT PIPELINE.BIOAG ALLIANCE - SEES ACCELERON B-300 SAT TO BE APPLIED TO BETWEEN 8-10 MILLION ACRES IN 2018, WHILE ACCELERON B-360 ST SCHEDULED TO ENTER MARKET IN 2019.BIOAG ALLIANCE - IN 2019-2020, PLAN TO LAUNCH PRODUCTS FOR GROWERS OF CORN, OILSEED RAPE AND WHEAT IN EUROPE.  Full Article

Novozymes Appoints Prisca Havranek-Kosicek New CFO
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - NOVOZYMES ::PRISCA HAVRANEK-KOSICEK NEW CFO.  Full Article